alexa Efficacy of Curcumin in Reducing Risk of Cardiovascular Disease in High Fat Diet-Fed Rats | Open Access Journals
ISSN: 1948-593X
Journal of Bioanalysis & Biomedicine
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Efficacy of Curcumin in Reducing Risk of Cardiovascular Disease in High Fat Diet-Fed Rats

El-Sayed M El-Habibi1*, Azza M El-Wakf1 and Abdullah Mogall2

1Faculty of Science, Mansoura University, Mansoura, Egypt

2Faculty of Education, Adan University, Adan, Yemen

*Corresponding Author:
El-Sayed M El-Habibi
Faculty of Science
Mansoura University
Mansoura, Egypt
E-mail: eelhabibi555@yahoo.com

Received Date: May 08, 2013; Accepted Date: July 08, 2013; Published Date: July 10, 2013

Citation: El-Habibi ESM, El-Wakf AM, Mogall A (2013) Efficacy of Curcumin in Reducing Risk of Cardiovascular Disease in High Fat Diet-Fed Rats. J Bioanal Biomed 5: 066-070. doi: 10.4172/1948-593X.1000082

Copyright: © 2013 El-Habibi ESM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Bioanalysis & Biomedicine

Abstract

This study aimed to explore mechanisms connecting obesity with incidence of cardiovascular disease (CVD) based on the changes in inflammatory response and hematological system. Also, to evaluate the role of curcumin in these changes. Obesity was induced by feeding male rats high fat diet (HFD) daily for three months, whereas curcumin (20 mg/kg b.wt) was given orally for the same period. Induction of obesity caused significant increase in the body weight gain with elevation in the levels of total lipids, total cholesterol and triglycerides in serum, aorta and heart. Shifts toward high inflammatory response, as evidenced by increased serum levels of tumor necrosis factoralpha (TNF-α) and C-reactive protein (CRP) were also observed. This goes with further elevation in total leucocytes, monocytes and lymphocytes, accompanied by decreased nitric oxide (NO) level in serum, aorta and cardiac tissue of
the HFD- group. A significant reduction in RBCs count, Hb content, MCV and MCHC %, with elevation in the platelet count and fibrinogen content were also recorded. However, curcumin administration to HFD- fed rats seemed to reduce the increase in body weight and to alleviate all the above mentioned changes. Thus, curcumin could serve as therapeutic agent for protecting against HFD-related CVD.

Keywords

Obesity; Curcumin; Cardiovascular disease; Inflammatory response; Hematological system

Introduction

Obesity is one of the major causes for incidence of cardiovascular disease (CVD) [1] which could be a result of hyperlipidemia, impaired glucose tolerance and hormonal imbalance [2]. However, recent research has indicated that CVD is probably begins and accelerated by other mechanisms potentiated through obesity, such as inflammation [3]. There is evidence that inflammation is the link between obesity and the related cardiovascular disorders. It was also demonstrated that obesity is a chronic inflammatory condition characterized by accumulation of macrophages in adipose tissue and liver, with increased release of inflammatory cytokines especially tumor necrosis factoralpha (TNF-α) from these macrophages [4]. Additionally, it was also reported that obesity is associated by elevated inflammatory markers such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) which are correlated with other CVD risk factors, including central distribution of body fat, high blood pressure, hyperglycemia and dyslipidemia [5].

Alterations in the hematological system have also considered to play crucial role in obesity-related CVD [6]. The most probable alteration include increased platelet aggregation and thrombus formation [7]. An increased WBCs [8] with reduced RBCs count [9] may also serve as contributing factors. Currently, much research has focused on the use of plant products, such as curcuminin healing different ailments. Curcumin is a natural product derived from the rhizomatous plant turmeric, which is widely used as spice and coloring agent [10]. Also, curcumin is commonly used in traditional medicine as an anti-inflammant. It has been demonstrated to lower the release of proinflammatory eicosanoids and to alleviate the swelling, morning stiffness, and other symptoms in arthritic patients [11]. Orally administered curcumin also lowered carrageenan-induced acute inflammation in rats [12]. In addition, curcumin has shown to inhibit angiogenesis in adipose tissue [13] and to protect against atherosclerosis and platelet aggregation [14]. Keeping into consideration the beneficial role of curcumin, the present study was designed to investigate if the use of this dietary spice would be effective in reducing incidence of CVD in HFD-fed male rats.

Materials and Methods

Experimental animals

This study was performed on male albino rats of Wistar strain, initially weighing 175 ± 5 g. Rats were obtained from the Institute of Ophthalmic Disease Research, Cairo. Egypt. They were housed in stainless steel cages at a well ventilated animal house. Rats were permitted adequate standard diet and given water ad libitum for one week of acclimatization period prior to the experimental work.

Chemicals

Curcumin [1.7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene- 3,5dione] the active constituent of the dietary spice turmeric was purchased from El-gomhoriaCompany for Chemicals, Mansoura, Egypt. All other reagents were of analytical grade and were purchased from local standard suppliers.

Research design

After one week of acclimatization, rats were randomly divided into five equal groups. The first was considered as control group, in which rats received normal laboratory diet (NLD) without supplementation. The second group was fed NLD and received 5% DMSO orally as vehicle with gastric tube at a dose 0.1 ml/100 g b.wt. In the third group, rats were received curcumin orally at dose of 20 mg/kg b.wt dissolved in 5% DMSO. Rats of the fourth group were fed on high fat diet (HFD) consisted of NLD in powder form mixed with melted animal abdominal fat (30%) and extra pure cholesterol (2%) [15], while rats of the fifth group were fed HFD and received curcumin orally at the same way and dose as described in the above groups. Rats administrated NLD and HFD daily for three months, while DMSO and curcumin were given every alternate day [16] for the same period. Care and use of the animals were conducted under supervision of the Animal Care Committee of Mansura University, Egypt

Samples collection

At the end of the experimental period, all rats were fasted overnight. At 8.00 in the morning, animals were weighed and sacrificed under ether anesthesia. Two blood samples were collected from each rat. The first blood sample was taken on EDTA as anticoagulant for determination of hematological parameters. The second blood sample was collected to obtain serum by centrifugation at 855g for 10 minutes. Sera were kept at -20°C for biochemical analysis. Immediately after collecting blood, the animals were dissected. heart, and aorta from each rat were removed, cleaned with saline solution (0.9%) and weighed. Samples of aorta and heart were then homogenized and the homogenate was kept frozen at-20°C until being analyzed.

Biochemical analysis

Total lipids (TLs) [17], total cholesterol (TC) [18], triglycerides (TGs) [19], C-reactive protein (CRP) [20] and nitric oxide (NO) [21] were estimated using kits supplied by Biodiagnostic Co., Mansoura, Egypt.

Inflammatory and hematologic analysis

Serum tumor necrosis factor-alpha (TNF-α) was measured, using ELIZA technique, according to [22]. Determination of fibrinogen was carried out using Multifibren – U – Kit, as described by [23]. Red blood cells (RBCs), platelets (PLts) and total white blood cells (WBCs) count were measured by hemocytometer neubauer slide, while differential count of WBCs was determined by Leishman’s stained blood film [24]. Hemoglobin (Hb) content was measured colorimetrically by Randox kits according to [25]. Mean corpuscular volume (MCV) and mean corpuscular hemoglobin concentration (MCHC) % were calculated using the formulae mentioned by [26].

Statistical analysis

All data were analyzed by one way analysis of variance (One–way ANOVA) followed by Least Significant Difference (LSD) test, using SPSS statistical package, version 17.00 software. The results were expressed as means ± S.E and values were considered to be statistically significant at P<0.05 [27].

Results

Administration of curcumin to normal rats did not produce any significant changes in all tested parameters in comparison to normal rats (Tables 1-3) indicating its nontoxic effect at the applied dose. Feeding rats on high fat diet (HFD) tended to exhibit a significant increase in the body weight gain compared to control rats. On the other hand, administration of curcumin to animals fed on HFD showed significantly reduced body weight compared to obese rats. The present obesity model also showed significant elevation in serum, heart and aorta TLs, TC, and TGs, accompanied by significant reduction of NO level in all tested tissues. Treatment of HFD-fed rats with curcumin significantly decreased various lipid parameters, while an elevation in NO levels in serum, aorta and heart was also recorded compared to non-treated HFD-group (Table 1).

Tested parameters Animal groups
Control DMSO CUR OB OB+CUR
Body weight gain (g) 118.67 ± 3.21 117.83 ±3.26 117.00 ±3.37 176.17 ± 3.53 a 151.67 ± 1 . 45 abc
SERUM TLs (mg/dl) 439.5 4 ± 8.01 438.2811.91 433 .08 ± 8 . 48 873.64 ± 7.92a 676.36  ± 10.83abc
TC(mg/dl) 101.96 ± 1.75 102.35 ± 2.45 101.15 ± 1.86 131.41   ± 1.76a 116.86    ± 3.41abc
TGs(mg/dl) 94. 98 ± 4. 07 94.37 ± 4.83 94.05 ± 1. 90 147.03 ± 4.87 a 127.29 ± 4.46abc
NO (µmol/L) 68.40 ± 2.75 68.24 ± 0.79 68.96 ± 1. 40 45.68  ± 1.43a 56.69 ± 1.79abc
AORTA TLs (mg/g) 68.74 ± 1.69 68.56 ± 1.45 68.09 ± 1.71 90.44 ± 1.31a 81.94 ± 1.73abc
TC (mg/g) 32.74 ± 1.32 32.59 ± 1.67 32.28 ± 1.54 48.02  ± 1.21a 41.28 ± 0.82abc
TGs (mg/g) 26.56 ± 2.12 26.38 ± 1.90 26.09 ± 1.38 40.59 ± 1.34a 34.55 ± 1.87ac
NO (µmol/g) 49.43 ± 1.30 49.11 ± 0.94 49.96 ± 1.82 30.81 ± 2.09 a 42.30 ± 0.82abc
HEART TLs (mg/g) 63.43 ± 0.98 63 .29 ± 1.00 63.06 ± 0.7 7 80.27   ± 1.42a 70.66  ± 1.82abc
TC (mg/g) 26.97 ± 1.81 26.72 ± 0.48 26.41 ± 1.01 42.61 ± 2.80a 35.88  ± 1.40abc
TGs (mg/g) 25.56 ± 1. 36 25.24 ± 1. 03 25.10 ± 0.90 35.93  ± 1.40a 31.67 ± 0.95ac
NO (µmol/g) 59.29 ± 0.97 59.18 ± 1. 77 59.92 ± 1.3 2 39.50  ± 1.85a 47.83  ± 1.54abc
ANOVA P<0.05

Table 1: Body weight gain and nitric oxide, as well as serumand tissue lipid profile in control and different treated rat groups.

Tested parameters Animal groups
Control DMSO CUR OB OB+CUR
CRP (mg/L) 14.83 ± 0.28 14.33 ± 0.76 14.00 ± 0.21 24.42 ± 0.90a 17.17 ± 0.54bc
TNF-α (pg/mg) 4.80 ± 0.12 4.63 ± 0.11 4.52 ± 0.15 8.83 ± 0.39a 6.72 ± 0.22abc
ANOVA P <0.05

Table 2: Serum TNF-α and CRP in control and different treated rat groups.

Tested Parameters Animal groups
Control DMSO CUR OB OB+CUR
RBCs (×103/µL) 6 .01 ± 0. 1 0 6 .05 ± 0. 1 2 6 . 1 0 ± 0. 1 4 5 .37 ± 0. 07 a 5 . 8 2 ± 0. 0 5 b
Hb(g/dL) 13.73 ± 0.11 13.60 ± 0.16 13. 55 ± 0. 13 8 .68a ± 0.24 10.98 ± 0.26abc
MCV  (ƒL) 6 8.83 ± 1.42 6 8. 0 7 ± 1. 44 67. 41 ± 1.59 60.85 ± 1.90a 6 7.74 ± 1.66 b
MCHC% 33.30 ± 0.53 33.09 ± 0.39 33.04 ± 0.38 26.64 ± 0. 51 a 27.9 8± 1.04 ac
WBC (×103/µL) /µL) 3 /µL) (×103/µL) 5.45 ± 0.05 5.52 ± 0.08 5.13 ± 0.08 6.67 ± 0.08 a 5.47 ± 0.17 b
Monocytes % 6.97 ± 0.31 6.83 ± 0.23 6.22 ± 0.17 8.57 ± 0. 37 a 7.82 ± 0.54 c
Lymphocytes % 45.73 ± 1.72 45.53 ± 0.63 45.05 ± 0.65 56.48 ± 0. 97a 47.27  ± 0.72 b
PLts(×103/µL) 453.83 ± 3.52 453.50 ± 1.65 453.17 ± 1.35 562.17 ± 4.80 a 477.33 ± 3.57abc
Fibrinogen(mg/dl) 117.834.04 117.331.76 117.1 7 4.42 260.8 2 6.54 a 212.1 6 2.96abc
ANOVA P <0.05

Table 3: Hematological parameters in control and different treated rat groups.

The present data also showed significantly increased serum CRP and TNF-α, in the HFD-rats. However; these changes seemed to be alleviated following curcumin treatment (Table 2). Elevations of fibrinogen level, PLts count, as well as WBCs, monocytes and lymphocytes, concomitantly with a reduction in RBCs count, Hb content, MCV and MCHC% were also recorded in the HFD-fed rats, in comparison with control group. On the other hand, feeding rats on HFD with curcumin administration caused an ameliorative effect on all these parameters, as evidenced by restoration of the changes in fibrinogen, platelets, WBCs and RBCs count, in addition to the other hematologic indices near to normal values (Table 3).

Discussion

Obesity is an independent risk factor for developing cardiovascular disease (CVD). Increased accumulation of lipids in the heart and blood vessels may be a major mechanism in this event [28]. However, further research has suggested involvement of other factors, including inflammation. It was indicated that inflammation may be a part of the causal chain that leads to cardiovascular disease [29]. It was also evidenced that obesity is associated with a condition of chronic inflammation, secondary to abnormal production of inflammatory cytokines, such as tumor necrosis factor -alpha (TNF-α) [4]. TNF-α acts primarily through activating NF-KB which is one of the transcription factors involved in mediating cellular inflammatory response [30]. An increased TNF-α expression and synthesis have been demonstrated with obesity, as being observed by [31] and the current study that showed marked elevation in serum TNF-α level, along with increased body weight gain in the HFD-fed rats.

TNF-α is suggested to play a key role in developing endothelial dysfunction and vascular injury through reducing nitric oxide (NO) production [32]. NO normally functions to maintain vascular homeostasis through a number of physiologic processes, including activation of soluble guanyl cyclase, which produces cyclic guanisine monophosphate (cGMP) being responsible for vasorelaxation [33]. NO can also act directly on calcium dependent potassium channels, leading to relaxation of vascular smooth muscles (SMCs) [34]. Based on this, the presently observed reduction in NO levels in both, aorta and heart of the obese rats may represent a major factor determining endothelial dysfunction and incidence of CVD.

Further explanation may involve increased C-reactive protein (CRP). An increased CRP was evidenced with obesity [35] confirming the present findings that showed significantly increased CRP level in the obese rats. For this inflammatory marker, previous study has indicated an association between elevated CRP and increased risk of myocardial infarction, peripheral arterial disease and coronary artery disease [36]. Such association seemed to occur primarily through enhancement of WBCs activity which further promotes cardiovascular injury. Thus, CRP may play an indirect role in developing CVD through its association with other risk factors such as WBCs [37]. It was reported that elevated WBCs count is an implication of systemic inflammatory reactions within the body. It involves the production of more white blood cells such as lymphocytes and monocytes. All these cells have their own important role in the inflammatory response [38]. Of importance in this concern is that leukocytes count is not just a marker for CVD, but it actually affects the vessel wall by cascade of inflammatory events that lastly lead to vascular injury. Among them is that activated leukocytes have increased tendency to adhere to vascular endothelium and to cause vascular injury through many stages, including movement of leucocytes, mainly monocytes into the subendothelial space with differentiation of these cells into macrophages and transformation into foam cells [39]. Accordingly, the present finding that HFD-fed rats showed elevated total and differential leukocytes (monocytes and lymphocytes) count may indicate high inflammatory response in this diet-induced obesity model.

An increase in the inflammatory response may enhance activation of leukocytes and endothelial cells, thereby promoting platelet aggregation and thrombus formation [40]. Moreover, increased number and activation of leukocytes and platelets promote formation of leukocyte-platelet aggregates which contribute to pathophysiological processes leading to increased risk for atherosclerotic lesions [8]. Platelets are cells that play a key role in the coagulation process. By adhering to damaged blood vessels, platelets become activated [41] resulting in changes in its shape and aggregation via cross-linking by intact fibrinogen which in turn modulates coagulation process [42]. Thus, elevation in the two hematological parameters, platelets and fibrinogen, as similarly described in the present study may indicate enhanced coagulation and thrombosis with increased tendency for CVD.

Beyond this effect, other hematological parameters, such as RBCs count may exert apparent influence in the genesis of CVD. A number of changes can affect RBCs, leading to reduction in their count which in turn may contribute to the risk of CVD [10]. It was indicated that RBCs are particularly exposed to oxidative hazards because of their specific role as oxygen carriers. Under normal physiologic conditions, there is a balance between production of ROS and their destruction by the endogenous antioxidant defense system [43]. However, the existing state of obesity with elevated lipid profile (TLs, TC,TGs) as seen in the current study and in other research [44] may increase generation of ROS and oxidative stress. This can damage both plasma membrane and cytosolic components, leading to oxidative hemolysis of RBCs and decreased survival of oxidized RBCs in circulation [45]. A finding which may provide an explanation for the present findings of decreased RBCs count and other hematological indices (Hb, MCV and MCHC%) in the obese rats. Decreased RBCs may lead to reduced rate of blood flow and oxygen diffusion through the RBCs membranes. This in turn may reduce the aerobic metabolism of glucose and fatty acids, leading to hypoxic state both in heart and endothelial cells, accompanied by cardiovascular injury often associated with obesity [46]. Currently, there is increasing interest in establishing non therapeutic ways for reducing obesity and its related health problems. Curcumin is a natural product derived from the herbal plant turmeric. It is a nontoxic agent having a wide variety of pharmacological activities [47]. In the present study, curcumin administration to HFD-rats succeeded to exert apparent cardiovascular protective action, which seemed to be mediated primary through reducing body weight gain. Besides, curcumin tended to exhibit marked anti-inflammatory properties, as evidenced from the reduction in the inflammatory markers, TNF-α and CRP, in parallel with further reduction in total and differential WBCs count. The antiinflammatory action of curcumin may be exerted through different pathways. First, curcumin has suppressive effect on production of the inflammatory cytokine TNF- α, which in turn leads to inhibition of NF-KB being responsible for promoting intracellular inflammation [48]. Additionally, curcumin was reported to lower production of CRP [49] and to cause marked decrease in WBCs count [50], which in all act as potential candidates for reducing enhanced inflammation. Apart from this, curcumin appeared to possess improving action on a number of hematological alterations. Curcumin was found to be effective in protecting RBCs against oxidative damage induced by direct application of H2O2 [51]. Also it can decrease lipid peroxidation in RBCs membranes by maintaining the activities of antioxidant enzymes, like SOD and CTA [52]. Previously, it was reported that increased ROS generation as in obesity is a key role for RBCs hemolysis, and reduced RBCs count and that curcumin protection may be mediated through scavenging free radicals and reducing oxidative stress [45]. The present observation that curcumin administration to HFD-rats increased RBCs count and other hemalogical indices (Hb, MCV, MCHC%) near to normal values in the HFD rats may thus indicate decreased rate of RBCs hemolysis which in turn may exert protection against cardiovascular injury. In association, curcumin was found to inhibit platelets aggregation, probably through interfering with cytosolic Ca2+ being responsible for platelets activation and aggregation [53]. Curcumin was reported also to inhibit fibrinogen synthesis and to reduce levels of fibrinogen [54]. As such, the present study showed reduced values of fibrinogen and platelet count when curcumin was administrated to HFD-rats, thus, indicating physiologic response for protecting against thrombosis and risk of CVD [55].

In conclusion, curcumin administration has shown to inhibit HFDrelated inflammation and hematological changes which ultimately prevent development of aorta and cardiac disorders. Curcumin may therefore recommended to be used as a functional food by subjects of expected CVD.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Conferences

Article Usage

  • Total views: 11861
  • [From(publication date):
    August-2013 - Jul 28, 2017]
  • Breakdown by view type
  • HTML page views : 8045
  • PDF downloads :3816
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords